Sign in
4

Changes in Ownership

PTC THERAPEUTICS, INC. Filed Acc 0001179110-22-000397

Chief Operating Officer sold 775 shares at $38.53 ($29,857)

  • Chief Operating Officer acquired 41,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Klein Matthew B. · Chief Operating Officer

Table I: Non-derivative

3 lines
Date Transaction Shares Price Value Owned after D/I
2022-01-07 Sale : show line 1 in the form −775 $38.53 $29,857 16,461 D
2022-01-07 Grant or award : show line 2 in the form +21,000 37,461 D
2022-01-07 Grant or award : show line 3 in the form +20,000 57,461 D
Open-market sales · 775 sh · avg $38.53 · $29,857

Table II: Derivative

2 lines
Date Transaction Shares Exercise Expires Underlying Owned after D/I
2022-01-07 Grant or award : show line 4 in the form Stock Option (Right to Buy) +52,500 $38.10 2032-01-06 52,500 52,500 D
2022-01-07 Grant or award : show line 5 in the form Stock Option (Right to Buy) +50,000 $38.10 2032-01-06 50,000 50,000 D
Loading xslF345X03/edgar.xml…